Bayer HealthCare AG
Bayer HealthCare AG, a prominent subsidiary of Bayer AG, is headquartered in Leverkusen, Germany. Established in 1863, the company has evolved into a global leader in the pharmaceutical and life sciences industry, with significant operations across Europe, North America, and Asia. Bayer HealthCare focuses on key business areas such as prescription pharmaceuticals, consumer health products, and animal health, offering innovative solutions that address critical health challenges. Its core products, including advanced therapies in oncology, cardiology, and women's health, are distinguished by their commitment to research and development. With a strong market position, Bayer HealthCare has achieved numerous accolades for its contributions to healthcare, consistently prioritising patient needs and scientific excellence. The company's dedication to innovation and quality continues to set it apart in a competitive landscape.
DitchCarbon Score
How does Bayer HealthCare AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer HealthCare AG's score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer HealthCare AG's reported carbon emissions
In 2021, Bayer HealthCare AG reported specific greenhouse gas emissions of approximately 0.07195 kg CO2e per €1,000 in external sales, reflecting their commitment to sustainability. This figure represents a decrease from 2020, where emissions were about 0.08655 kg CO2e per €1,000 in external sales. While the company has not disclosed absolute emissions data or specific reduction targets, it is actively engaged in initiatives to enhance its environmental performance. Bayer's emissions data does not specify Scope 1, 2, or 3 emissions, indicating a need for further transparency in their reporting. Despite the absence of detailed reduction targets or commitments to the Science Based Targets initiative (SBTi), Bayer's focus on reducing emissions intensity demonstrates a proactive approach to climate responsibility. Overall, Bayer HealthCare AG is making strides in managing its carbon footprint, although more comprehensive data and explicit targets would strengthen its climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer HealthCare AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
